Press release
Biologics and Biosimilars Market Growing Tremendously During 2023-2030 Key Players: Sandoz International GmbH (Novartis division), CELLTRION INC., Amgen Inc.
Biosimilars are similar to reference drugs. However, they exhibit a minor difference in clinically inactive components. They are identical in terms of safety, effectiveness, and clinical significance as their reference product. Biologics are produced from living organisms by using complex manufacturing processes. A wide variety of biologics are available such as monoclonal antibodies, therapeutic proteins, vaccines, and others. These are active substances obtained from living cells of plants or animals. Biosimilars are approximately 20-25% cheaper than their reference/branded products. Moreover, biologics are used in the treatment of a wide variety of indications such as osteoporosis, arthritis, cystic fibrosis, autoimmune disorders, and cancer. For instance, some of the approved biosimilars are Mvasi (Avastin), Erelzi (Enbrel), Ogivri (Herceptin), Amjevita (Amjevita), among others.The report also includes the profiles of key Biologics and Biosimilars Market companies along with their SWOT analysis and market strategies. In addition, this report discusses the key drivers influencing market growth, opportunities, challenges and risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Ask for a sample report on this Market now! @
https://globalmarketvision.com/sample_request/176986
Top vendors of Biologics and Biosimilars Market:
• Pfizer Inc.
• Intas Pharmaceuticals Ltd.
• Biocon
• Dr. Reddy's Laboratories Ltd.
• Sandoz International GmbH (Novartis division)
• CELLTRION INC.
• Amgen Inc.
• STADA Arzneimittel AG
• Apotex Inc.
• Biogen
The market is split into further categories based on Market By Type:
• Monoclonal Antibodies
• Interferon
• Erythropoietin
• Insulin
• Vaccines
• Others
The market is split into further categories based on Market By Application:
• Tumor
• Diabetes
• Cardiovascular
• Hemophilia
• Others
Analysts of this research report focus on various business strategies and Biologics and Biosimilars market tactics that can contribute to the progress of businesses. Leading key players have been highlighted to understand the competition in the industry across the globe. North America, Latin America, Europe, Asia-Pacific, and India have been examined on the basis of several factors like productivity, manufacturing base, and product types. The competitive landscape has been gauged to get a clear picture of the current scope for the existing industries.
Request for Buy Report @
https://globalmarketvision.com/checkout/?currency=USD&type=single_user_license&report_id=176986
Analysts of this research report focus on various business strategies and Biologics and Biosimilars market tactics that can contribute to the progress of businesses. Leading key players have been highlighted to understand the competition in the industry across the globe. North America, Latin America, Europe, Asia-Pacific, and India have been examined on the basis of several factors like productivity, manufacturing base, and product types. The competitive landscape has been gauged to get a clear picture of the current scope for the existing industries.
In This Study, The Years Considered To Estimate The Size Of Biologics and Biosimilars Market Are As Follows:
History Year: 2015-2022
Base Year: 2022
Estimated Year: 2023
Forecast Year 2023 to 2030
If you have any special requirements, please let us know and we will offer you the report as you want.
Get in Touch with Us
Sarah Ivans | Business Development
Phone: +1 617 297 8902
Email: sales@globalmarketvision.com
Global Market Vision
Website: www.globalmarketvision.com
About Global Market Vision
Global Market Vision consists of an ambitious team of young, experienced people who focus on the details and provide the information as per customers' needs. Information is vital in the business world, and we specialize in disseminating it. Our experts not only have in-depth expertise but can also create a comprehensive report to help you develop your own business.
With our reports, you can make important tactical business decisions with the certainty that they are based on accurate and well-founded information. Our experts can dispel any concerns or doubts about our accuracy and help you differentiate between reliable and less reliable reports, reducing the risk of making decisions. We can make your decision-making process more precise and increase the probability of success of your goals.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biologics and Biosimilars Market Growing Tremendously During 2023-2030 Key Players: Sandoz International GmbH (Novartis division), CELLTRION INC., Amgen Inc. here
News-ID: 3203727 • Views: …
More Releases from Global Market Vision

Rapid Growth in Solar Pump Market Driven by Clean Energy Demand and Government I …
[Pune, India] - [10/07/2025] - [Global Market Vision], a leading provider of market intelligence, has released its latest report on the Solar Pump Market, projecting significant growth driven by rising demand for renewable energy solutions, increasing agricultural modernization, and supportive government policies worldwide.
According to the GMV, the global solar pump market is expected to grow at a CAGR of 33%, reaching INR 60 billion by 2024. This growth is fueled…

5G in Healthcare: The Next Frontier for Innovation and Patient Care
Market Overview:
The fundamental components of healthcare could all be changed and enhanced by 5G networks. Over the past several years, the use of 5G networks in healthcare has increased, and their applications have been strengthened by advancements in robotics, IoT, and AI that will change healthcare systems into a new connected ecosystem. The main challenge faced by healthcare systems is the fastest transmission of data.
5G technology is revolutionizing the healthcare…

Dual Screen Laptops Market Size, Share, Trends, Growth Report and Forecast
The global dual-screen laptops market is witnessing steady growth, with a forecasted increase from $2.59 billion in 2023 to $3.26 billion by 2028, driven by a compound annual growth rate (CAGR) of about 5.0%. This growth is fueled by advancements in display technology, the rising demand for portable devices, and the growing popularity of dual-screen laptops among gamers, content creators, and professionals who benefit from the enhanced multitasking capabilities these…

Active & Intelligent Packaging Market Market Data and In-depth Analysis to 2032 …
Future Market Consulting Global Market Vision has published a research report on the "Global Active & Intelligent Packaging Market", which provides a comprehensive outline of the factors responsible for the market growth from 2018 to 2032. The Active & Intelligent Packaging Market value is USD XX million in 2023 and is expected to grow to USD XX million by 2032 with a CAGR of XX% during the forecast period. …
More Releases for Biosimilars
Transformative Trends Impacting the Biosimilars Market Landscape: Innovative Pro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Biosimilars Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The dimensions of the biosimilars market have been rapidly expanding over the last couple of years. The escalation, from a worth of $18.65 billion in 2024 to an estimated value of $21.95 billion in 2025, denotes…
Evolving Market Trends In The Biosimilars Industry: Innovative Product Launched …
The Biosimilars Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Biosimilars Market Size During the Forecast Period?
The dimension of the biosimilars market has experienced substantial expansion in the last few years. The market value, which was at $18.65 billion in 2024,…
Prominent Rituximab Biosimilars Market Trend for 2025: Collaborative Innovations …
Which drivers are expected to have the greatest impact on the over the rituximab biosimilars market's growth?
The rituximab biosimilars market is anticipated to grow due to the projected increase in non-Hodgkin's lymphoma (NHL) cases. NHL is a cancer that originates in the white blood cells and lymphocytes, which are integral parts of the body's immune system. For example, the American Cancer Society, a cancer advocacy group based in the US,…
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure.
According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is…
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased.
According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was…
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million…